AbCellera (ABCL)
10.89
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 AbCellera Biologics Inc. For: Aug 24 Filed by: Hayden Michael R
August 24, 2026 5:22 PM - SEC Filing
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
August 19, 2026 8:56 AM - StreetInsider
Form 4 AbCellera Biologics Inc. For: Aug 18 Filed by: Montalbano John S.
August 18, 2026 2:45 PM - SEC Filing
Form 4 AbCellera Biologics Inc. For: Aug 14 Filed by: Booth Andrew
August 14, 2026 12:04 PM - SEC Filing
Form 4 AbCellera Biologics Inc. For: Aug 12 Filed by: Hayden Michael R
August 14, 2026 11:50 AM - SEC Filing
Form 8-K AbCellera Biologics Inc. For: Aug 12
August 13, 2026 4:36 PM - SEC Filing
Form 424B5 AbCellera Biologics Inc.
August 13, 2026 4:34 PM - SEC Filing
Form 4 AbCellera Biologics Inc. For: Aug 11 Filed by: Hayden Michael R
August 13, 2026 3:02 PM - SEC Filing
AbCellera prices $200M public offering of shares and warrants
August 13, 2026 12:06 AM - StreetInsider
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
August 13, 2026 12:05 AM - BizWire
Form 424B5 AbCellera Biologics Inc.
August 11, 2026 5:00 PM - SEC Filing
These Have the Market Hot Zone Catalysts and Setups
August 11, 2026 4:52 PM - StreetInsider
AbCellera launches $200M public offering of common stock
August 11, 2026 4:01 PM - StreetInsider
AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
August 11, 2026 4:01 PM - BizWire
AbCellera Biologics (ABCL) PT Raised to $15 at BMO Capital
August 11, 2026 7:44 AM - StreetInsider
AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
August 11, 2026 7:07 AM - StreetInsider
The Catalysts are Back: Socket Mobile Breaks Out while Biotechs Race Toward Major Milestones
August 10, 2026 10:40 AM - StreetInsider
AI Found an Influenza Target That Survives Viral Mutation
August 10, 2026 9:10 AM - StreetInsider
Form 8-K AbCellera Biologics Inc. For: Aug 10
August 10, 2026 7:49 AM - SEC Filing
AbCellera Phase 2 trial shows ABCL635 cuts hot flash frequency by 83%
August 10, 2026 7:00 AM - StreetInsider
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profi
August 10, 2026 7:00 AM - BizWire
Form 8-K AbCellera Biologics Inc. For: Aug 07
August 7, 2026 4:44 PM - SEC Filing
AbCellera to release phase 2 trial data for menopause drug Aug. 10
August 7, 2026 4:30 PM - StreetInsider
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026
August 7, 2026 4:30 PM - BizWire
AbCellera Biologics (ABCL) PT Raised to $9 at Stifel
August 6, 2026 8:09 AM - StreetInsider
Form 10-Q AbCellera Biologics Inc. For: Jun 30
August 5, 2026 4:30 PM - SEC Filing
Form 8-K AbCellera Biologics Inc. For: Aug 05
August 5, 2026 4:23 PM - SEC Filing
AbCellera (ABCL) Misses Q2 EPS by 1c
August 5, 2026 4:06 PM - StreetInsider
AbCellera Reports Q2 2026 Business Results
August 5, 2026 4:05 PM - BizWire
Form 8-K AbCellera Biologics Inc. For: Jul 29
July 29, 2026 11:39 AM - SEC Filing
AbCellera and Vertex team up on T-cell engager drugs for autoimmune
July 29, 2026 7:00 AM - StreetInsider
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
July 29, 2026 7:00 AM - BizWire
Cantor Fitzgerald Reiterates Overweight Rating on AbCellera Biologics (ABCL)
July 17, 2026 9:55 AM - StreetInsider
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
July 7, 2026 4:05 PM - BizWire
Benchmark Upgrades AbCellera Biologics (ABCL) to Buy
July 7, 2026 6:16 AM - StreetInsider
Form 4 AbCellera Biologics Inc. For: Jul 01 Filed by: Seely Lynn
July 6, 2026 6:21 PM - SEC Filing
Form 3 AbCellera Biologics Inc. For: Jun 30 Filed by: Seely Lynn
July 6, 2026 6:15 PM - SEC Filing
Form 4 AbCellera Biologics Inc. For: Jul 01 Filed by: Sandor Victor
July 6, 2026 6:05 PM - SEC Filing
Form 8-K AbCellera Biologics Inc. For: Jun 30
July 6, 2026 2:54 PM - SEC Filing
AbCellera adds Lynn Seely to its board of directors
July 6, 2026 9:00 AM - StreetInsider
AbCellera Appoints Dr. Lynn Seely to its Board of Directors
July 6, 2026 9:00 AM - BizWire
Form 8-K AbCellera Biologics Inc. For: Jun 17
June 17, 2026 12:38 PM - SEC Filing
Jazz Pharmaceuticals and AbCellera ink antibody research deal
June 17, 2026 7:01 AM - StreetInsider
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
June 17, 2026 7:00 AM - BizWire
Full Article List
